“…The inhibitory effects of RESV on cell cycle have been previously demonstrated, as has its ability to mediate tumour cell death selectively through necrosis, apoptosis, autophagy and other mechanisms, although evidence is emerging that certain normal cells such as endothelial cells, lymphocytes, chondrocytes and adipocytes are vulnerable to RESV [27][28][29][30]. Likewise, RESV inhibits proliferation and promotes apoptosis of several tumour lines, such as osteosarcoma, epidermoid carcinoma, macroglobulinemia malignant cells or breast cancer cells [15,16,18,20]. Furthermore, in the majority of studies, RESV inhibits cell proliferation and induces apoptosis via different mechanisms [29,30].…”